UTI-Pharma & Healthcare Fund (G)
|
UTI-Pharma & Healthcare Fund (G)
| Summary Info |
|
Fund Name
|
: |
UTI Mutual Fund
|
|
Scheme Name
|
: |
UTI-Pharma & Healthcare Fund (G)
|
|
AMC
|
: |
UTI Mutual Fund
|
|
Type
|
: |
Open
|
|
Category
|
: |
Equity - Pharma
|
|
Launch Date
|
: |
27-May-99
|
|
Fund Manager
|
: |
Lalit Nambiar
|
|
Net Assets (Rs. cr)
|
: |
110.17
|
|
|
|
|
|
NAV Date
|
: |
17-May-13
|
|
NAV [Rs.]
|
: |
51.5
|
|
Buy/Resale Price [Rs.]
|
: |
51.54
|
|
Sell/Repurchase Price [Rs.]
|
: |
51.54
|
|
Entry Load %
|
: |
NIL
|
|
Exit Load %
|
: |
<3 Years - 1%.
>= 3 Years - NIL.
|
|
|
|
|
|
|
|
|
|
|
|
Performance(%)
* returns above 1 yr. are annualized
|
|
1w
|
1m
|
3m
|
6m
|
1y
|
3y
|
5y
|
Since INC
|
|
Scheme Returns
|
3.7 |
7.3 |
13.2 |
15.3 |
27.4 |
14.1 |
16.7 |
11.4 |
|
Category Avg
|
4.3 |
7.5 |
13.3 |
13.6 |
31.0 |
15.4 |
20.2 |
14.2 |
|
Category Best
|
4.9 |
8.0 |
13.8 |
15.9 |
36.3 |
19.4 |
24.6 |
24.9 |
|
Category Worst
|
3.7 |
7.0 |
13.0 |
11.7 |
27.4 |
14.1 |
14.9 |
5.3 |
|
|
|
|
|
|
|
Dividends
|
Bonus
|
|
Ratio
|
NA
|
NA
|
|
Date
|
NA
|
NA
|
|
|
|
|
|
Tax Benefits :
|
54EA |
|
Min. Investment(Rs.) :
|
5,000.00 |
|
Increm.Investment(Rs.) :
|
1,000.00 |
|
|
|
|
In
|
|
Name of the Company
|
No of shares
|
|
No fresh investments made in
|
|
|
|
|
Out
|
|
Name of the Company
|
No of shares
|
|
No investments sold out
|
|
|
|
|
Fund Holdings
As on 31-Mar-2013
| Asset Type | Instrument Name | Industry | Net Assets
(%) | No of Shares | Mkt Value
(Cr.) | | Equity & Equity related Investments | | Equity | eq sun pharmaceuticals industries ltd. | Pharmaceuticals | 21.0 | 261,440 | 21.4 | | Equity | eq dr. reddy's laboratories ltd. | Pharmaceuticals | 15.4 | 88,766 | 15.7 | | Equity | eq cipla ltd. | Pharmaceuticals | 12.0 | 321,990 | 12.2 | | Equity | eq lupin ltd. | Pharmaceuticals | 8.6 | 138,879 | 8.7 | | Equity | eq glaxosmithkline pharmacueticals ltd. | Pharmaceuticals | 7.1 | 32,697 | 7.2 | | Equity | eq wyeth ltd. | Pharmaceuticals | 4.6 | 52,171 | 4.7 | | Equity | eq divis laboratories ltd. | Pharmaceuticals | 4.4 | 44,963 | 4.4 | | Equity | eq glenmark pharmaceuticals ltd | Pharmaceuticals | 3.7 | 82,095 | 3.8 | | Equity | eq pfizer limited | Pharmaceuticals | 2.8 | 27,146 | 2.9 | | Equity | eq ranbaxy laboratories ltd. | Pharmaceuticals | 2.6 | 59,268 | 2.6 | | Equity | eq strides arcolab ltd. | Pharmaceuticals | 2.0 | 23,452 | 2.0 | | Equity | eq biocon ltd. | Pharmaceuticals | 2.0 | 74,104 | 2.0 | | Equity | eq sun pharma advanced research co ltd. | Miscellaneous | 2.0 | 175,386 | 2.0 | | Equity | eq cadila healthcare ltd. | Pharmaceuticals | 1.7 | 23,603 | 1.8 | | Equity | eq piramal enterprises ltd. | Pharmaceuticals | 1.6 | 26,332 | 1.6 | | Equity | eq sanofi india ltd. | Pharmaceuticals | 1.4 | 5,606 | 1.5 | | Equity | eq unichem laboratories | Pharmaceuticals | 1.2 | 67,740 | 1.2 | | Equity | eq indoco remedies ltd. | Pharmaceuticals | 0.6 | 112,852 | 0.7 | | Equity | eq dishman pharmaceuticals & chemicals ltd. | Pharmaceuticals | 0.4 | 58,000 | 0.4 | | Equity | eq shasun pharmaceuticals ltd. | Pharmaceuticals | 0.1 | 18,750 | 0.1 | | Term Deposits | | Fixed Deposits | sterm-dep: bank of baroda | -/- | 0.1 | NA | 0.1 | | Cash & Cash Equivalent | | Net CA & Others | net current assets | -/- | 4.9 | NA | 5.0 |
|
|